대한약학회 추계총회 및 학술대회 (2015년) A study on the development of clinical protocol to prove non-inferiority of alectinib over ceritinib in crizotinib-resistant and ALK-positive NSCLC patients

학술대회자료

A study on the development of clinical protocol to prove non-inferiority of alectinib over ceritinib in crizotinib-resistant and ALK-positive NSCLC patients

대한약학회
추계총회 및 학술대회
(2015년)
2015.10

789 - 789 (1 pages)

커버이미지 없음

원문보기

원문저장

A study on the development of clinical protocol to prove non-inferiority of alectinib over ceritinib in crizotinib-resistant and ALK-positive NSCLC patients

(0)

(0)

(0)

(0)

A study on the development of clinical protocol to prove non-inferiority of alectinib over ceritinib in crizotinib-resistant and ALK-positive NSCLC patients

(0)

(0) 팝업 열기 팝업 닫기

(0)

(0)

(0)